SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,000 | -95.1% | 140 | -89.1% | 0.00% | -100.0% |
| Q1 2019 | $204,000 | -45.6% | 1,280 | -67.3% | 0.01% | -55.6% |
| Q4 2018 | $375,000 | -40.9% | 3,911 | -12.8% | 0.02% | -21.7% |
| Q3 2018 | $634,000 | -11.9% | 4,485 | -2.5% | 0.02% | -14.8% |
| Q2 2018 | $720,000 | -97.1% | 4,602 | -97.0% | 0.03% | -97.3% |
| Q1 2018 | $24,630,000 | -11.4% | 152,913 | -9.4% | 0.99% | -7.8% |
| Q4 2017 | $27,801,000 | +489.6% | 168,785 | +123.0% | 1.07% | +457.8% |
| Q3 2017 | $4,715,000 | -67.6% | 75,679 | -58.6% | 0.19% | -68.4% |
| Q2 2017 | $14,559,000 | +41.3% | 182,804 | +26.1% | 0.61% | +43.7% |
| Q1 2017 | $10,306,000 | – | 145,018 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |